LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00066667
 30.90 27.76 424 2032 0.2086 0.5529
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 30.90 27.76 1541 2032 0.7582 0.9126
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 32.60 27.76 88 2235 0.0394 0.1999
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 32.60 27.76 2147 2235 0.9603 0.9872
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 32.60 27.76 511 2235 0.2286 0.5841
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 32.60 27.76 1800 2235 0.8051 0.9327
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 34.30 27.76 98 2449 0.0400 0.2155
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 34.30 27.76 2314 2449 0.9446 0.9824
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 34.30 27.76 654 2449 0.2670 0.6304
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 34.30 27.76 1941 2449 0.7923 0.9293
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 36.01 27.76 121 2662 0.0454 0.2506
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 36.01 27.76 2510 2662 0.9426 0.9821
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 36.01 27.76 719 2662 0.2700 0.6393
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 36.01 27.76 2083 2662 0.7822 0.9268
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 37.71 27.76 133 2877 0.0462 0.2636
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 37.71 27.76 2662 2877 0.9251 0.9769
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 37.71 27.76 801 2877 0.2784 0.6523
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 37.71 27.76 2214 2877 0.7694 0.9232
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 39.41 27.76 150 3105 0.0483 0.2813
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 39.41 27.76 2828 3105 0.9106 0.9727
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 39.41 27.76 888 3105 0.2859 0.6639
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 39.41 27.76 2381 3105 0.7667 0.9234
MN20160318_Q01
D12
MCF 10A-H2B-mCherry Trametinib
0.00066667
 41.11 27.76 168 3331 0.0504 0.2978
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 41.11 27.76 3017 3331 0.9056 0.9715
MN20160318_Q01
C19
MCF 10A-H2B-mCherry Trametinib
0.00066667
 41.11 27.76 1036 3331 0.3110 0.6888
MN20160318_Q01
D12